The FY2025 (Dec) proxy of Nektar Therapeutics names 19 peer companies for pay. Among Nektar Therapeutics and these peers, CEO pay was 7th highest of 13 and total shareholder return was 12th highest of 13.
7th highest of 13in Nektar Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:
$2.3M$9.7M
12th highest of 13in Nektar Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:
$17$1,020
Pay peer group, FY2025 (Dec) proxy
| Arcus Biosciences | ||
| IDEAYA Biosciences | ||
| Praxis Precision Medicines | ||
| Vir Biotechnology | ||
| Corvus Pharmaceuticals | ||
| Vera Therapeutics | ||
| Celldex Therapeutics | ||
| Compass Therapeutics | ||
| Intellia Therapeutics | ||
| Relay Therapeutics | ||
| Olema Pharmaceuticals | ||
| Gossamer Bio | ||
| Amylyx Pharmaceuticals | Not disclosed | Not disclosed |
| Astria Therapeutics | Not disclosed | Not disclosed |
| Dianthus Therapeutics | Not disclosed | Not disclosed |
| Immunome Bothell | Not disclosed | Not disclosed |
| Kodiak Sciences | Not disclosed | Not disclosed |
| Rezolute | Not disclosed | Not disclosed |
| Viridian Therapeutics | Not disclosed | Not disclosed |
'%20fill='%23FEFEFE'%3e%3cpath%20d='M67.7444739,25%20L33.1043073,38.2478027%20L34.7958615,41.1131448%20L41.0490807,51.7151219%20L29.0986607,51.7151219%20L28,54.6065381%20L57.1428867,79%20L60.0675871,77.3612019%20L46.8800441,55.0029363%20L63.0277166,55.0032886%20L63.8216155,51.7151219%20L70,26.9178624%20L67.7444739,25%20Z%20M38,39.9222264%20L66,29%20L60.3908123,52%20L44.9725093,52%20L38,39.9222264%20Z%20M34,55%20L43.1090246,55%20L52,70%20L34,55%20Z'%20id='Fill-1-Copy'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
19 companies
Changes by year
FY2024 (Dec) proxy
- RemovedAlpine Immune Sciencespay peer groupCompared to the 2023 peer group, the 2024 peer group differs in that two companies, Alpine Immune Sciences and NGM Bio, were removed on account that these two companies had either been acquired or were in the process of being acquired
- RemovedNGM Biopay peer groupCompared to the 2023 peer group, the 2024 peer group differs in that two companies, Alpine Immune Sciences and NGM Bio, were removed on account that these two companies had either been acquired or were in the process of being acquired
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.